4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-059512
Chief Medical Officer sold 15,000 shares at an average $45.43 ($681,438)
- Chief Medical Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crystal Adam Chief Medical Officer | 2021-10-01 | Option exercise | +15,000 | $4.98 | $74,700 | 15,000 | D |
| Crystal Adam Chief Medical Officer | 2021-10-01 | Sale | −1,712 | $44.25 | $75,756 | 13,288 | D |
| Crystal Adam Chief Medical Officer | 2021-10-01 | Sale | −8,176 | $45.32 | $370,563 | 5,112 | D |
| Crystal Adam Chief Medical Officer | 2021-10-01 | Sale | −5,112 | $45.99 | $235,119 | 0 | D |
| Derivatives | |||||||
| Crystal Adam Chief Medical Officer | 2021-10-01 | Option exercise · Stock Option (Right to Buy) | −15,000 | 168,108 | D | ||
| Open-market sales · 15,000 sh · avg $45.43 · $681,438 | |||||||
Loading xslF345X03/doc4.xml…